NCT00618254已完成不适用
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 1
- 主要终点
- Bioequivalence
研究概览
简要总结
The objective of this study was to assess bioequivalence of a potential generic 1 mg granisetron tablet formulation compared with Roche Laboratories' 1 mg granisetron tablet, Kytril, following a single 1 mg dose, under fasting conditions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No clinically significant abnormal finding on the physical examination, medical history, or clinical laboratory results during screening.
排除标准
- •Positive test for HIV, Hepatitis B, or Hepatitis C.
- •Treatment with known enzyme altering drugs.
- •History of allergic or adverse response to granisetron or any other comparable or similar drug.
结局指标
主要结局
Bioequivalence
时间窗: Baseline, four period, 7 day washout
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fed ConditionsNauseaVomitingNCT00618111Roxane Laboratories32
已完成
1 期
Granisetron 1 mg Tablets Under Fasting ConditionsHealthyNCT00834717Teva Pharmaceuticals USA40
已完成
1 期
Granisetron 1 mg Tablets, Non-fastingHealthyNCT00834522Teva Pharmaceuticals USA80
已完成
1 期
Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese VolunteersHealthy SubjectsNCT04424381The Affiliated Hospital of Qingdao University72
已完成
不适用
Bioequivalency Study of Clarithromycin Tablets Under Fed ConditionsInfectionNCT00602498Roxane Laboratories28